Andrew M. Kidger

969 total citations
13 papers, 686 citations indexed

About

Andrew M. Kidger is a scholar working on Molecular Biology, Oncology and Epidemiology. According to data from OpenAlex, Andrew M. Kidger has authored 13 papers receiving a total of 686 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Epidemiology. Recurrent topics in Andrew M. Kidger's work include Melanoma and MAPK Pathways (7 papers), Protein Tyrosine Phosphatases (6 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Andrew M. Kidger is often cited by papers focused on Melanoma and MAPK Pathways (7 papers), Protein Tyrosine Phosphatases (6 papers) and Cytokine Signaling Pathways and Interactions (3 papers). Andrew M. Kidger collaborates with scholars based in United Kingdom, United States and Norway. Andrew M. Kidger's co-authors include Stephen M. Keyse, Simon J. Cook, Ole Morten Seternes, Christopher J. Caunt, Chris Bryant, Linda Rushworth, David Oxley, Kathryn Balmanno, Rebecca Gilley and Hanneke Okkenhaug and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Molecular Cell.

In The Last Decade

Andrew M. Kidger

13 papers receiving 682 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Andrew M. Kidger United Kingdom 10 543 155 90 82 73 13 686
Rebecca Gilley United Kingdom 12 564 1.0× 176 1.1× 95 1.1× 94 1.1× 92 1.3× 14 723
Fritz Lai Australia 11 476 0.9× 156 1.0× 117 1.3× 64 0.8× 107 1.5× 11 585
Madhavi Bathina United States 8 597 1.1× 183 1.2× 70 0.8× 102 1.2× 98 1.3× 10 771
Lynn Ueno United States 9 630 1.2× 221 1.4× 76 0.8× 148 1.8× 42 0.6× 13 910
Anna Gajos-Michniewicz Poland 14 504 0.9× 168 1.1× 66 0.7× 183 2.2× 34 0.5× 18 650
Tammy Flagg United States 12 654 1.2× 243 1.6× 66 0.7× 130 1.6× 67 0.9× 19 809
Yahao Bu United States 12 323 0.6× 146 0.9× 83 0.9× 63 0.8× 46 0.6× 16 515
Sarah A Molton United States 7 436 0.8× 183 1.2× 48 0.5× 62 0.8× 32 0.4× 8 535
Andrew Olaharski United States 14 354 0.7× 111 0.7× 113 1.3× 155 1.9× 60 0.8× 21 642
Jiuxiang Zhu United States 11 576 1.1× 161 1.0× 67 0.7× 85 1.0× 71 1.0× 11 1.0k

Countries citing papers authored by Andrew M. Kidger

Since Specialization
Citations

This map shows the geographic impact of Andrew M. Kidger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andrew M. Kidger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andrew M. Kidger more than expected).

Fields of papers citing papers by Andrew M. Kidger

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andrew M. Kidger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andrew M. Kidger. The network helps show where Andrew M. Kidger may publish in the future.

Co-authorship network of co-authors of Andrew M. Kidger

This figure shows the co-authorship network connecting the top 25 collaborators of Andrew M. Kidger. A scholar is included among the top collaborators of Andrew M. Kidger based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andrew M. Kidger. Andrew M. Kidger is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Balmanno, Kathryn, Andrew M. Kidger, Dominic P. Byrne, et al.. (2023). ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1. Biochemical Journal. 480(9). 587–605. 6 indexed citations
2.
Kidger, Andrew M., Mark K. Saville, Linda Rushworth, et al.. (2022). Suppression of mutant Kirsten-RAS (KRASG12D)-driven pancreatic carcinogenesis by dual-specificity MAP kinase phosphatases 5 and 6. Oncogene. 41(20). 2811–2823. 9 indexed citations
3.
Ferguson, Bradley S., Sara A. Wennersten, Kimberly Demos-Davies, et al.. (2021). DUSP5-mediated inhibition of smooth muscle cell proliferation suppresses pulmonary hypertension and right ventricular hypertrophy. American Journal of Physiology-Heart and Circulatory Physiology. 321(2). H382–H389. 9 indexed citations
4.
Lochhead, Pamela A., Julie A. Tucker, Natalie J. Tatum, et al.. (2020). Paradoxical activation of the protein kinase-transcription factor ERK5 by ERK5 kinase inhibitors. Nature Communications. 11(1). 1383–1383. 33 indexed citations
5.
Kidger, Andrew M., Joanne M. Munck, Harpreet K. Saini, et al.. (2019). Dual-Mechanism ERK1/2 Inhibitors Exploit a Distinct Binding Mode to Block Phosphorylation and Nuclear Accumulation of ERK1/2. Molecular Cancer Therapeutics. 19(2). 525–539. 17 indexed citations
6.
Walker, Simon, David Oxley, Andrew M. Kidger, et al.. (2019). An mTORC1-to-CDK1 Switch Maintains Autophagy Suppression during Mitosis. Molecular Cell. 77(2). 228–240.e7. 70 indexed citations
7.
Kidger, Andrew M., et al.. (2018). ERK1/2 inhibitors: New weapons to inhibit the RAS-regulated RAF-MEK1/2-ERK1/2 pathway. Pharmacology & Therapeutics. 187. 45–60. 133 indexed citations
8.
Seternes, Ole Morten, Andrew M. Kidger, & Stephen M. Keyse. (2018). Dual-specificity MAP kinase phosphatases in health and disease. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1866(1). 124–143. 103 indexed citations
9.
Kidger, Andrew M., Linda Rushworth, Chris Bryant, et al.. (2017). Dual-specificity phosphatase 5 controls the localized inhibition, propagation, and transforming potential of ERK signaling. Proceedings of the National Academy of Sciences. 114(3). E317–E326. 67 indexed citations
10.
Lebraud, Honorine, Rebecca Gilley, Andrew M. Kidger, et al.. (2017). Visualization of Endogenous ERK1/2 in Cells with a Bioorthogonal Covalent Probe. Bioconjugate Chemistry. 28(6). 1677–1683. 8 indexed citations
11.
Caunt, Christopher J., Andrew M. Kidger, & Stephen M. Keyse. (2016). Visualizing and Quantitating the Spatiotemporal Regulation of Ras/ERK Signaling by Dual-Specificity Mitogen-Activated Protein Phosphatases (MKPs). Methods in molecular biology. 1447. 197–215. 3 indexed citations
12.
Kidger, Andrew M. & Stephen M. Keyse. (2016). The regulation of oncogenic Ras/ERK signalling by dual-specificity mitogen activated protein kinase phosphatases (MKPs). Seminars in Cell and Developmental Biology. 50. 125–132. 163 indexed citations
13.
Rushworth, Linda, Andrew M. Kidger, Laurent Delavaine, et al.. (2014). Dual-specificity phosphatase 5 regulates nuclear ERK activity and suppresses skin cancer by inhibiting mutant Harvey-Ras (HRas Q61L )-driven SerpinB2 expression. Proceedings of the National Academy of Sciences. 111(51). 18267–18272. 65 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026